JPRN-UMIN000016442
Completed
未知
A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating. - A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating.
Izumo-City General Medical Center0 sites80 target enrollmentFebruary 4, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Izumo-City General Medical Center
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients receiving daikenchuto or other Japanese traditional herbal medicine within 4 weeks before enrolled in this study If not stable doses of the follow medications are taken for at least 2 weeks before enrolled to this study: acid suppressant, prokinetics, calcium polycarbophil, anticholinergic drug, laxative, antidepressant, anti\-anxiety agent. Patients with organic lesion like cancer. Patients with serious coexisting disease (e.g. Hepatic, renal, cardiac, hematological, or metabolic disorder). Lactating or pregnant mother or women who wish to become pregnant during the study period. Determined not applicable for this study by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to investigate safety and efficacy on a combined use of rituximab and auto-gamma/delta T cell therapy for CD20-positive B-cell lymphoma.CD20-positive B-cell lymphomaJPRN-UMIN000003641Japanese Red Cross Medical Center15
Completed
Phase 1
Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cellsMalignant GliomaJPRN-UMIN000001903Osaka National Hospital, National Hospital Organization15
Completed
Not Applicable
Clinical study to investigate safety and efficacy on combination of gemcitabine and autologous gamma/delta T cell transfer therapy after resection of pancreatic cancerPancreatic cancerJPRN-UMIN000000931The University of Tokyo Hospital30
Completed
Not Applicable
A clinical study investigating the safety, efficacy and performance of the URECA CTO device.ArteriosclerosisChronic Total Occlusion(s)10003216NL-OMON55292reca B.V.40
Completed
Phase 2
Effect of Chawayan Shakti Powder(An Ayurvedic polyherbal combination) in improving physical health and immunity.CTRI/2022/10/046368KAG Industries, Nahan H.P35